BASF

What BASF does

BASF Pharma Solutions is the pharmaceutical ingredients arm of BASF SE, the publicly listed German multinational chemical company (Frankfurt Stock Exchange: BAS) founded in 1865 as Badische Anilin- und Soda-Fabrik. The unit manufactures active pharmaceutical ingredients (APIs), pharmaceutical excipients, chemical intermediates, and fine-chemical catalysts for the global pharmaceutical industry, claiming the position of world's largest manufacturer of APIs such as ibuprofen and omega-3 fatty acids, and operator of the world's largest portfolio of chemical raw materials for the pharmaceutical industry, spanning more than 700 intermediates (Building Blocks, Chiral Auxiliaries, Protective Groups, Reagents, and Solvents). Product offerings are organized across five drug delivery platforms — Orals, Topicals, Parenterals, Solubilization, and Biopharma Ingredients — reflecting the unit's horizontal segmentation strategy across solid oral, dermal, injectable, solubility-challenged, and biologic dosage forms.

The business operates a B2B enterprise model, selling APIs, excipients, and intermediates under quote-based, one-time-purchase commercial terms to pharmaceutical, nutraceutical, and cosmetics customers worldwide. Distribution combines direct enterprise sales by a global team of industry experts and product specialists with two proprietary digital platforms: myBASFWorld, a customer portal providing centralized product documentation, regulatory information, ordering, and real-time shipment tracking; and ZoomLab, a digital formulation development and optimization tool. The firmographics indicate a U.S. footprint anchored in Florham Park, New Jersey, with 10,000+ employees referenced for the U.S. operations, alongside broader European (Germany) and Asia Pacific (China, India) presence.

Revenue mechanics are anchored in volume manufacturing of bulk APIs and a broad intermediates catalog rather than licensed or recurring software revenue; the input discloses no specific revenue, pricing, or ARR figures for the Pharma Solutions unit. The unit has executed bolt-on M&A, including Polymer Ventures in January 2019 and AgriMetis in September 2020, and continues to invest in digital tooling as a customer engagement layer around its physical product portfolio.

Name

BASF

Legal name

BASF SE

Website

https://pharma.basf.com

Company type

Public

Founded year

1865

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

BASF Pharma Solutions manufactures active pharmaceutical ingredients, excipients, and chemical intermediates for global pharmaceutical, nutraceutical, and cosmetics companies, operating across five drug delivery platforms and supported by the myBASFWorld and ZoomLab digital platforms.

Ownership category

akta.pro rank

Product category

Pharmaceutical Ingredients

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industries

Biologic API/Drug Substance Manufacturing Services (HLAAAKAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical excipients
• Drug delivery platforms
• Chemical intermediates
• Fine chemical catalysts

Headquarters

HQ city

Florham Park

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (APIs): Manufacturing and sale of APIs including ibuprofen and omega-3 fatty acids; world's largest manufacturer of these products
2. Pharmaceutical Excipients: Production and supply of innovative excipients for pharmaceutical formulations
3. Chemical Intermediates: Portfolio of more than 700 products including Building Blocks, Chiral Auxiliaries, Protective Groups, Reagents and Solvents for chemical synthesis in pharmaceutical industry
4. Catalysts: Fine-chemical catalysts and metals-management services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

BASF Pharma Solutions manufactures and supplies active pharmaceutical ingredients (APIs), pharmaceutical excipients, and chemical intermediates for the global pharmaceutical industry. The business operates across dedicated drug delivery platforms (Orals, Topicals, Parenterals, Solubilization, Biopharma Ingredients) and provides a chemical intermediates portfolio of more than 700 products plus fine-chemical catalysts with metals-management services, supported by the myBASFWorld and ZoomLab digital platforms.

Product overview

BASF Pharma Solutions is a comprehensive pharmaceutical portfolio offering a diverse range of products organized across multiple drug delivery platforms: Orals, Topicals, Parenterals, Solubilization, and Biopharma Ingredients. As the world's leading manufacturer of active pharmaceutical ingredients (APIs) including ibuprofen and omega-3 fatty acids, BASF provides innovative excipients and active ingredients supported by digital platforms myBASFWorld and ZoomLab. The portfolio includes a chemical intermediates portfolio of more than 700 products (Building Blocks, Chiral Auxiliaries, Protective Groups, Reagents, and Solvents) and fine-chemical catalysts with metals-management services. The myBASFWorld portal provides centralized access to technical data, regulatory information, ordering, and shipment tracking, while ZoomLab offers formulation tools for pharmaceutical development.

Differentiator

Problem solved

Functional benefit

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Johnson Matthey: British specialty chemicals company with a Health division offering APIs, controlled substances and fine chemicals for pharma. Comparable to BASF in pharmaceutical materials, with overlap particularly in catalysts and active ingredients.
• Cambrex: US-based contract development and manufacturing organization (CDMO) specializing in small-molecule APIs and intermediates. Direct peer to BASF's chemical intermediates and API manufacturing business, serving similar pharma customers.
• Lonza Group: Swiss-based global CDMO and API manufacturer offering small-molecule APIs, biologics manufacturing and drug delivery platforms. Directly comparable to BASF Pharma Solutions across APIs, excipients and biopharma ingredients, with comparable B2B enterprise sales motion to global pharma customers.
• Siegfried Holding: Swiss specialty manufacturer of active pharmaceutical ingredients and intermediates serving the global pharma industry. Direct peer in small-molecule API and chemical intermediates with overlapping product portfolio and customer base.
• Avantor: US-based supplier of mission-critical products and services to customers in the life sciences and advanced technologies industries, with a strong excipients and bioprocessing portfolio. Direct peer to BASF in excipients, buffers and biopharma ingredients for pharma manufacturing.
• Evonik Industries: German specialty chemicals company with a Health Care business line producing APIs, excipients and drug delivery solutions (e.g., RESOMER polymers, EUDRAGIT coatings). Closely comparable to BASF Pharma Solutions in pharmaceutical polymers, excipients and API manufacturing for global pharma.
• Pfizer CentreOne: Pfizer's contract manufacturing and API services arm offering small-molecule API manufacturing and intermediates to external pharma customers. Direct peer to BASF in contract API supply, leveraging Pfizer's manufacturing infrastructure.
• DSM-Firmenich: Dutch nutrition and pharma ingredients company producing APIs, vitamins, and pharmaceutical excipients including omega-3. Directly comparable to BASF in omega-3 and nutraceutical-pharma crossover products.

Broad incumbents

• Merck KGaA (Life Science): German multinational with a Life Science division supplying pharma/biopharma manufacturing inputs including excipients, APIs and process chemicals. Broader portfolio than BASF Pharma Solutions (also includes lab supplies and electronics) but a major direct competitor in pharmaceutical raw materials.
• DuPont (Electronics & Industrial / Healthcare): US diversified chemicals company with a Healthcare segment producing excipients and biopharma processing materials. Broader portfolio than BASF Pharma Solutions but overlapping in pharmaceutical excipients and process solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BASF_Pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BASF